| 000 | 01196 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515110543.0 | ||
| 264 | 0 | _c20080520 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a0340-9937 | ||
| 024 | 7 |
_a10.1007/s00059-008-3074-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHurlen, Mette | |
| 245 | 0 | 0 |
_aOral anticoagulation after myocardial infarction. _h[electronic resource] |
| 260 |
_bHerz _cFeb 2008 |
||
| 300 |
_a38-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xmortality |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThromboembolism _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aArnesen, Harald | |
| 773 | 0 |
_tHerz _gvol. 33 _gno. 1 _gp. 38-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00059-008-3074-8 _zAvailable from publisher's website |
| 999 |
_c17778405 _d17778405 |
||